VENUSREMEDIES.COM KEYWORD DENSITY CHECKER

Total words: 762 | 2-word phrases: 198 | 3-word phrases: 211 | 4-word phrases: 214

PAGE INFO

Title Try to keep the title under 60 characters (62 characters)
Venus Remedies - Indian research driven pharmaceutical company
Description Try to keep the meta description between 50 - 160 characters (186 characters)
We are a fully integrated company, known for R&D initiatives, world class manufacturing facilities, rich IP Wealth, strong marketing network worldwide and highly efficient professionals.
Keywords Meta keywords are not recommended anymore (186 characters)
Indian Pharmaceutical Company, Pharmaceutical Industry, Healthcare Products, Research Pharmaceutical Company, Pharmaceutical Company, Antibiotic Resistance, Antibiotic Resistance Breaker, Antimicrobial Resistance, Enjoying Innovation, AMR, Antibiotic
H1 No H1 tag on the page (0 characters)

ONE WORD PHRASES 139 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1venus1410.07%
2remedies85.76%
3to64.32%
4the53.60%
5a53.60%
6and53.60%
7presence42.88%
8in42.88%
9you42.88%
10our42.88%

TWO WORD PHRASES 198 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1venus remedies84.04%
2in a31.52%
3remedies limited31.52%
4use of21.01%
5venus pharma21.01%
6at venus21.01%
7diversity equity21.01%
8saudi arabia21.01%
9in azerbaijan21.01%
10about us21.01%
11venus pharmaceutical21.01%
12this site21.01%
13remedies secures21.01%
14better browsing10.51%
15arabia championing10.51%
16paclitaxel zoledronic10.51%
17zoledronic acid10.51%
18acid and10.51%
19and bleomycin10.51%
20bleomycin from10.51%

THREE WORD PHRASES 211 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1venus remedies limited31.42%
2venus remedies secures20.95%
3paclitaxel zoledronic acid10.47%
4saudi arabia and10.47%
5arabia and philippines10.47%
6and philippines venus10.47%
7philippines venus remedies10.47%
8venus remedies receives10.47%
9remedies receives regulatory10.47%
10approvals for paclitaxel10.47%
11for paclitaxel zoledronic10.47%
12zoledronic acid and10.47%
13remedies secures mas10.47%
14acid and bleomycin10.47%
15and bleomycin from10.47%
16bleomycin from the10.47%
17philippinessaudi arabia championing10.47%
18arabia championing diversity10.47%
19championing diversity equityinclusion10.47%
20diversity equityinclusion venus10.47%
21bags gptw venus10.47%
22from saudi arabia10.47%
23pharmaceutical market venus10.47%
24market venus remedies10.47%
25for enoxaparin in10.47%
26venus remedies enoxaparin10.47%
27gains approval in10.47%
28approval in azerbaijan10.47%
29in azerbaijan venus10.47%
30azerbaijan venus remedies10.47%

FOUR WORD PHRASES 214 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1venus remedies limited uses10.47%
2philippines venus remedies receives10.47%
3pharmaceutical market venus remedies10.47%
4market venus remedies secures10.47%
5venus remedies secures mas10.47%
6from saudi arabia and10.47%
7saudi arabia and philippines10.47%
8arabia and philippines venus10.47%
9and philippines venus remedies10.47%
10venus remedies receives regulatory10.47%
11850 million pharmaceutical market10.47%
12approvals for paclitaxel zoledronic10.47%
13for paclitaxel zoledronic acid10.47%
14paclitaxel zoledronic acid and10.47%
15zoledronic acid and bleomycin10.47%
16acid and bleomycin from10.47%
17and bleomycin from the10.47%
18philippinessaudi arabia championing diversity10.47%
19arabia championing diversity equityinclusion10.47%
20million pharmaceutical market venus10.47%
21a 850 million pharmaceutical10.47%
22bags gptw venus remedies10.47%
23azerbaijan venus remedies secures10.47%
24presence responsibility contact us10.47%
25responsibility contact us featured10.47%
26contact us featured venus10.47%
27us featured venus remedies10.47%
28featured venus remedies enoxaparin10.47%
29gains approval in azerbaijan10.47%
30approval in azerbaijan venus10.47%
31in azerbaijan venus remedies10.47%
32venus remedies secures marketing10.47%
33into a 850 million10.47%
34remedies limited uses cookies10.47%
35authorization for enoxaparin in10.47%
36for enoxaparin in azerbaijan10.47%
37enoxaparin in azerbaijan a10.47%
38in azerbaijan a strategic10.47%
39azerbaijan a strategic move10.47%
40a strategic move to10.47%

EXTERNAL LINKS

# URL Whois Check
1https://www.vmrcindia.com/ Whoisvmrcindia.com
2 https://www.vmrcindia.com/events Whoisvmrcindia.com
3 https://www.venuspharmagmbh.de/ Whoisvenuspharmagmbh.de